Literature DB >> 27145870

European Union investment and countries' involvement in mental health research between 2007 and 2013.

J-B Hazo1,2,3,4, J Gervaix1,2,3, C Gandré1,2,3,4, M Brunn1,2,3,4, M Leboyer4,5,6,7, K Chevreul1,2,3,8.   

Abstract

OBJECTIVES: This study aimed to estimate the commitment to mental health research by the European Union (EU) through the 7th framework (FP7) and the competitiveness and innovation (CIP) programmes during the 2007-2013 period.
METHODS: Research projects dedicated or partially related to mental health were identified using keywords in the CORDIS database that inventories all FP7 and CIP research projects. We then contacted projects' principal investigators to access the budget breakdown by country and performed an imputation of the distribution of funding between countries based on projects' and participants' characteristics where information was missing.
RESULTS: Among the 25 783 research projects funded by the FP7 and the CIP, 215 (0.8%) were specifically dedicated to mental health and 170 (0.7%) were partially related to mental health. They received €607.1 million representing 1.4% of FP7 total funding. Within the FP7-Health subprogramme, the projects represented 5.2% of funding. Important variations appeared across EU countries both for raw funding, which varied between €0 and €77M, and for funding per 100 inhabitants, which varied between €0 and €293.
CONCLUSION: EU funding of mental health research does not match the burden incurred by mental disorders and must be increased in the next framework programme.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  financial management; mental health; research

Mesh:

Year:  2016        PMID: 27145870     DOI: 10.1111/acps.12584

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  1 in total

1.  Is there a fair allocation of healthcare research funds by the European Union?

Authors:  Zoltán Kaló; Loek Hendrik Matheo van den Akker; Zoltán Vokó; Marcell Csanádi; János György Pitter
Journal:  PLoS One       Date:  2019-04-15       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.